Volume 21, Number 7—July 2015
Seroprevalence for Hepatitis E and Other Viral Hepatitides among Diverse Populations, Malawi
|Study name, period (reference)||Study site/setting||Study type||Study population||HIV status||Aims of study|
|ICAR,1989–1994 (21,22)||Queen Elizabeth Central Hospital, Blantyre/urban||Observational cohort||Pregnant and postpartum women||+/–||Assess adverse pregnancy outcomes and rates of mother-to-child transmission of HIV|
|SUCOMA, 1998 (23)||Nchalo District, sugar estate/rural, occupational||Observational survey||Adult men||+/–||Identify epidemiologic and biologic determinants of HIV infection in an occupational male cohort|
|NVAZ, 2000–2004 (24)||Queen Elizabeth Central Hospital, Blantyre/urban||Randomized clinical trial||Pregnant women||+||Assess efficacy of short antiretroviral post-exposure prophylaxis to prevent mother to child transmission of HIV|
|MWANZA, 2001 (T.E. Taha, unpub. data)||Mwanza District/rural||Observational survey||Adult men and women||+/–||Assess risk factors associated with prevalent HIV infection in a rural area adjacent to the borders with Mozambique|
|METRO, 2003–2005 (25)||Queen Elizabeth Central Hospital; health centers in Blantyre/urban||Randomized clinical trial||Adult women (nonpregnant)||+/–||Assess the efficacy of intermittent intravaginal metronidazole gel use in reducing bacterial vaginosis infection|
|PEPI, 2004–2008 (26)||Queen Elizabeth Central Hospital; health centers in Blantyre/urban||Randomized clinical trial||Pregnant women||+||Assess efficacy of extended antiretroviral postexposure prophylaxis to prevent mother to child transmission of HIV|
*ICAR, International Collaborations on AIDS Research; SUCOMA, a study of prevalence among male workers for the Sugar Company of Malawi; NVAZ, a study of efficacy of nevirapine/zidovudinel postexposure prophylaxis to prevent mother-to-child transmission of HIV; MWANZA, a study of risk factors associated with prevalent HIV infection in the rural town of Malawi; METRO, a study in which efficacy of intravaginal metronidazole gel in reducing bacterial vaginosis was assessed; PEPI, a study of antiretroviral postexposure prophylaxis to prevent mother to child transmission of HIV.
- Labrique AB, Kuniholm MH, Nelson K. The global impact of hepatitis E: new horizons for an emerging virus. In: Scheld WM, Grayson ML, Hughes JM, editors. Emerging Infections 9. 9th edition. Herndon (VA): ASM Press; 2010. p. 53–92.
- Teshale EH, Hu DJ, Holmberg SD. The two faces of hepatitis E virus. Clin Infect Dis. 2010;51:328–34 .
- Nelson KE, Kmush B, Labrique AB. The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients. Expert Rev Anti Infect Ther. 2011;09:1133–48.
- Jacobs C, Chiluba C, Phiri C, Lisulo MM, Chomba M, Hill PC, Seroepidemiology of hepatitis E virus infection in an urban population in Zambia: strong association with HIV and environmental enteropathy. J Infect Dis. 2014;209:652–7.
- Gerbi GB, Williams R, Bakamutumaho B, Liu S, Downing R, Drobeniuc J, Hepatitis E as a cause of acute jaundice syndrome in northern Uganda, 2010–2012. Am J Trop Med Hyg. 2015;92:411–4.
- Ahmed JA, Moturi E, Spiegel P, Schilperoord M, Burton W, Kassim NH, Heptitis E outbreak, Dadaab refugee camp, Kenya, 2012. Emerg Infect Dis. 2013;19:1010–2.
- Menendez C, Sanchez-Tapias JM, Kahigwa E, Mshinda H, Costa J, Vidal J, Prevalence and mother-to-child transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol. 1999;58:215–20.
- Stark K, Poggensee G, Hohne M, Bienzle U, Kiwelu I. Schre ier E. Seroepidemiology of TT virus, GBC-C/HGV, and hepatitis viruses B, C, and E among women in rural area of Tanzania. J Med Virol. 2000;62:524–30.
- Kim J-H, Nelson KE, Panzner U, Kasture Y, Labrique AB, Wierzba TF. A systematic review of the epidemiology of hepatitis E virus in Africa. BMC Infect Dis. 2014;14:308.
- Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28:6653–7.
- World Health Organization. Hepatitis B 2014 [cited 11/03/2014]. http://www.who.int/mediacentre/factsheets/fs204/en/
- World Health Orgamization. Hepatitis C 2014 [cited 11/03/2014]. http://www.who.int/mediacentre/factsheets/fs164/en/#
- Barth RE, Huijgen Q, Taljaard J, Hoepelman AI. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis. 2010;14:e1024–31.
- Ocama P, Seremba E. Management of HIV and hepatitis C virus infections in resource-limited settings. Curr Opin HIV AIDS. 2010;6:539–45.
- Chasela CS, Wall P, Drobeniuc J, King CC, Teshale E, Hosseinipour MC, Prevalence of hepatitis C virus infection among human immunodeficiency virus-1–infected pregnant women in Malawi: the BAN study. J Clin Virol. 2012;54:318–20.
- Mullis CE, Laeyendecker O, Reynolds S, Ocama P, Jeffrey Quinn J, Boaz I, High frequency of false-positive hepatitis C virus enzyme-linked immunosorbent assay in Rakai, Uganda. Clin Infect Dis. 2013;57:1747–50.
- Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: epidemiology and prevention in developing countries. World J Hepatol. 2012;4:74–80.
- Nyirenda M, Beadsworth MB, Stephany P, Hart CA, Munthali C, Beeching NJ, Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. J Infect. 2008;57:72–7.
- Sutcliffe S, Taha TE, Kumwenda NI. Taylor, Liomba GN. HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi. J Acquir Immune Defic Syndr. 2002;31:90–7.
- Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, Hossain A, Epidemiology and risk factors of incident hepatitis E virus infections in rural Bangladesh. Am J Epidemiol. 2010;172:952–61.
- Miotti PG, Dallabetta GA, Chiphangwi JD, Liomba G, Saah AJ. A retrospective study of childhood mortality and spontaneous abortion in HIV-1 infected women in urban Malawi. Int J Epidemiol. 1992;21:792–9.
- Taha TE, Dallabetta GA, Hoover DR, Chiphangwi JD, Mtimavalye LA, Liomba GN, Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. AIDS. 1998;12:197–203.
- Kumwenda NI, Taha TE, Hoover D, Markakis D, Liomba NG, Chiphangwi JD, Three surveys of HIV-1prevalence and risk factors among men working at a sugar estate in Malawi. Sex Transm Dis. 2002;29:366–71.
- Taha TE, Kumwenda NI, Gibbons A, Broadhead RL, Fiscus S, Lema V, Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet. 2003;362:1171–7.
- Taha TE, Kumwenda N, Kafulafula G, Makanani B, Nkhoma C, Chen S, Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and infected women: a randomized clinical trial. PLoS Clin Trials. 2007;2:e10.
- Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008;359:119–29.
- Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol. 2010;82:799–805.
- Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Archives of Orofacial Sciences. 2006;1:9–14.
- Malawi Demographic and Health Survey 2010: Final Report. National Statistics Office of Malawi (Zomba, Malawi) and MEASURE DHS/ICF Macro (Calverton, USA); 2011 [cited 11/03/2014]. http://dhsprogram.com/pubs/pdf/FR247/FR247.pdf
- Kuniholm MH, Labrique AB, Nelson KE. Should HIV-infected patients with unexplained chronic liver enzyme elevations be tested for hepatitis E Virus? Clin Infect Dis. 2010;50:1545–6.